Effects of bovine enterovirus and type 1 diabetes on liver and kidney pyruvate kinase activity in an animal model

Type 1 diabetes (T1D) is an autoimmune disease characterized by the selective destruction of pancreatic beta cells. In addition to genetic factors, enteroviruses have been considered the main environmental factor involved in this pathology. Therefore, the objective of this study was to evaluate the effects of streptozotocin-induced diabetes and bovine enterovirus (BEV) on liver and kidney pyruvate kinase activity in rats. Fourteen male Wistar rats were divided in three groups: control, diabetes and a third group, which was fed with water experimentally contaminated by BEV. Increased blood glucose levels were found in both diabetes and enterovirus groups, whereas there were no alterations in the lipid profile. A reduced pyruvate kinase activity was observed in the liver and kidney of animals from diabetes and enterovirus groups. Under our experimental conditions, the ingestion of water experimentally contaminated by BEV induced alterations in glycaemia, and also interfered in the pyruvate kinase activity in liver and kidney of the rats, which might be one of the possible mechanisms involved in the T1D development.

Effects of chronic exposure to hexavalent chromium in water on oxidative stress parameters in Wistar rats

Hexavalent chromium [Cr (VI)] is a metal utilized in different industries and consequently disposed in the environment. It is a toxic substance and its reduction to trivalent Cr [Cr (III)] generates intermediates, which are responsible for the oxidation of molecules, and cause the oxidative stress. Therefore, the aim of this study was to evaluate if Cr (VI) could induce oxidative stress in Wistar rats. In this study, Wistar rats were chronically exposed to 25 and 50 ppm of potassium dichromate in drinking water for 30 days. The levels of Cr were evaluated in the blood and tissues (liver, kidneys, and lungs). Oxidative stress was determined in the liver, kidneys, and lungs and was evaluated by DFCH, TBA-RS and carbonyl test. Antioxidant enzymes were evaluated through catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities. Regarding the results, Cr concentration was significantly elevated in all tissues, however, it was lower in the lungs. In relation to the oxidative stress parameters, there was a significant increase of DCFH levels in the kidneys and carbonyls in liver and kidneys. Regarding the antioxidant enzymes, SOD was decreased in all organs and GPx was diminished in the kidneys. These data indicated that Cr (VI) could induce oxidative stress in the kidneys and liver due to an imbalance between oxidative and antioxidant parameters. The lungs were little affected, possibly by the lowest chromium accumulation.

Relationship between depression and diabetes Mellitus / Relação entre depressão e diabetes Mellitus

Objective: To review studies examining the possible relationship between depression and diabetes Mellitus.Methods: Articles were searched in the following databases: the Latin-American and Caribbean Center on Health Sciences, the Scientific Library Online, Base in Nursing and Pubmed. The search was limited to articles published between January 2000 and October 2010. Search terms included: ?diabetes?, ?depression?, ?chronic diseases? and ?psychiatric disorders? Results: A total of 21 articles which examined the relationship between diabetes and depression were included in the present paper. There is a bidirectional relationship between these two chronic diseases. Diabetes could lead to depression due its effects on the quality life of patients, its complications and the difficulty in treatment adhesion. Depression could lead to diabetes on account of alterations in glucose transport function and increased immunoninflamatory activation, which could contribute to insulin resistance and beta islet cell dysfunction. Conclusion: There is a bidirectional relation between diabetes and depression and the nature of this relation is still unclear. However, this research contributes to the comprehension of this relation and possible mechanisms involved, since both diseases should be monitored and deserve attention from health professionals.

Objetivo: Revisar estudos que avaliaram a possível existência da relação entre depressão e diabetes Mellitus.Métodos: Artigos foram pesquisados nas seguintes bases de dados: Literatura Latino-Americana e do Caribe em Ciências da Saúde, Scientific Electronic Library Online, Bases de Dados em Enfermagem e Pubmed. A busca foi limitada aos artigos publicados de janeiro de 2000 a outubro de 2010. Os termos de busca utilizados foram ?diabetes?, ?depressão?, ?doenças crônicas? e ?distúrbios psiquiátricos? Resultados: Um total de 21 artigos que avaliaram a relação entre diabetes e depressão foi incluído e analisado no presente trabalho. Há uma relação bidirecional entre essas duas doenças crônicas. O diabetes poderia levar à depressão por afetar a qualidade de vida dos pacientes, dadas suas complicações e a dificuldade de adesão ao tratamento. A depressão poderia ocasionar o diabetes devido às alterações na função do transporte de glicose e ao aumento da ativação da resposta imunoinflamatória, o que poderia contribuir para a resistência à insulina e para a disfunção da célula betapancreática. Conclusão: Existe uma relação bidiretional entre diabetes e depressão, e a natureza dessa relação permanece desconhecida. Esta revisão contribui para a compreensão dessa relação e dos possíveis mecanismos envolvidos, visto que ambas as doenças devem ser monitoradas e merecem atenção dos profissionais da saúde.

Frequency of the anti-glutamic acid decarboxylase immunological marker in patients with diabetes duration longer than three years in southern Brazil / Frequência do marcador imunológico de anti-decarboxilase do ácido glutâmico em pacientes com diabetes há mais de três anos no Sul do Brasil

CONTEXT AND OBJECTIVE: The anti-GAD (glutamic acid decarboxylase) antibody is considered to be an important marker for type 1 diabetes mellitus (DM1), with frequency that varies depending on the population studied and the duration of the disease. Therefore, the aim of this study was to determine the frequency of this autoantibody in a group of patients in southern Brazil with DM1 that had been diagnosed more than three years previously. DESIGN AND SETTING: Analytical cross-sectional study with a control group conducted at the Biomedicine Laboratory of Universidade Feevale. METHODS: This study was conducted between June 2007 and December 2008, and 109 individuals were enrolled during this period. Fifty-eight were DM1 patients and 51 were individuals free from DM1 and without any history of diabetes, who constituted the control group. RESULTS: In the DM1 group, the mean age was 27 ± 1.7 years and 50 percent were men. The mean fasting blood glucose in the DM1 group was 208 ± 15 mg/dl and mean HbA1c (glycosylated hemoglobin) was 8.7 ± 0.25 percent. In the control group, the mean fasting blood glucose and HbA1c were 82 mg/dl and 5.0 percent respectively. Thirty-seven individuals with DM1 (63.8 percent) were positive for anti-GAD, and this proportion was significantly larger than in the control group. CONCLUSIONS: These results show the high prevalence of anti-GAD in the population of diabetic patients in southern Brazil, thus indicating that the antibody was still present a long time after the disease had been diagnosed.

CONTEXTO E OBJETIVO: O anticorpo anti-decarboxilase do ácido glutâmico (anti-GAD) é considerado um importante marcador no diabetes mellitus tipo 1 (DM1), cuja frequência varia segundo a população estudada e o tempo de duração da doença. Assim, o objetivo deste estudo foi determinar a frequência deste auto-anticorpo em um grupo de pacientes localizados no Sul do Brasil com mais de três anos de diagnóstico de DM1. TIPO DE ESTUDO E LOCAL: Estudo transversal analítico com grupo controle, realizado no Laboratório de Biomedicina da Universidade Feevale. MÉTODOS: Este estudo foi realizado no período de Junho de 2007 a Dezembro de 2008, em que 109 indivíduos foram incluídos, sendo 58 destes com DM1 e 51 indivíduos sem DM1 e sem antecedentes de diabetes, que constituíram o grupo controle. RESULTADOS: No grupo DM1, a idade média foi 27 ± 1,7 anos e 50 por cento eram homens. A média da glicemia de jejum no grupo DM1 foi 208 ± 15 mg/dL e a HbA1c média foi 8,7 ± 0.25 por cento. No grupo controle a glicemia de jejum média e a HbA1c (hemoglobina glicosilada) foram 82 mg/dL e 5,0 por cento, respectivamente. O anti-GAD foi positivo em 37 (63,8 por cento) indivíduos com DM1, valores significativamente maiores quando comparados com os do grupo controle. CONCLUSÕES: Estes resultados mostram a alta prevalência do anti-GAD na população de pacientes diabéticos da região Sul do Brasil, indicando que o anticorpo está presente após um longo período de diagnóstico da doença.